The Health-System Pharmacist's Role in Optimizing Outcomes for Patients Who Need DOAC Reversal Agents
This activity will provide the pharmacist with the knowledge and skills necessary to take a leadership role in developing policies or guidelines for anticoagulation reversal and to assist in the design of the optimal anticoagulation reversal regimen at the bedside.
Improving the Performance of Specialty Pharmacists in the Care of Patients with Pulmonary Arterial Hypertension
This activity will provide a disease state overview, summarize PAH treatments and recommendations for management, and incorporate updates from the recently published consensus documents from the 6th World
Formulary Considerations: Evaluating the Use of Direct Oral Anticoagulant Reversal Agents in Health-Systems
This activity will help pharmacists understand DOAC reversal agents, and highlight factors to consider when implementing protocols for anticoagulation reversal agents.
An American Journal of Managed Care® Webcast: PCSK9 Inhibitor Data Updates and the Implications to Population Health
Upon completion of this educational activity, participants will be able to examine the incidence of hypercholesterolemia within health plan populations, including levels of severity.